As of August 28, 2026, UroGen Pharma Ltd. (URGN) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. UroGen Pharma Ltd. has a market capitalization of $1.37B, 48.88M shares outstanding, 174 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise
model 15%
• Under 12 months cash (9mo)
Market Data
Market Cap$1.37B
Shares Outstanding48.88M
Float43.18M
Cash$109.30M
Debt$188.73M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 14.4% shares (2026Q1 vs prior)
174 institutional holders · 53.57M shares
#1
MORGAN STANLEY
7.65M shares
#2
RTW INVESTMENTS, LP
4.54M shares
#3
BlackRock, Inc.
2.85M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest4.59M
Days to Cover6.6
% of Float10.6%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2025-12-31
xbrl
XBRL WARRANT
2024-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual URGN Dilution Snapshot
UroGen Pharma Ltd. (URGN) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for URGN: xbrl on 2025-12-31; xbrl on 2024-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track URGN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking URGN — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for URGN
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.